Testing effectiveness (Phase 2)UnknownNCT01964157
What this trial is testing
An Open-label, Multicenter, Phase II Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Yonsei University 32